Cytoreductive nephrectomy offers survival benefit in metastatic kidney cancer
The results of a trial looking at immunotherapy treatment with [...]
ESMO 2019: Kidney cancer tumour shrinkage in patients who did not have surgery
This interview with Dr Monty Pal, Associate Professor from the [...]
Is there a role for cytoreductive nephrectomy?
This discussion with Dr Paul Russo presents a case for [...]
The role of cytoreductive nephrectomy in metastatic kidney cancer
Around 12,500 new cases of renal cell carcinoma (RCC) are [...]
Cytoreductive surgery with immunotherapy for kidney cancer patients
In this video clip, Professor Eric Jonasch, Medical Oncologist, Division [...]
ASCO 2019: Immunotherapy before surgery for treating metastatic kidney cancer
The results of this open-label pilot study were presented at [...]
ASCO 2019: Analysis of CARMENA trial results using IMDC risk groups
The results from CARMENA, a randomised phase III clinical trial [...]
ASCO GU 2019: Questions and lessons moving forward from CARMENA: A medical oncologist’s perspective
The following paper was presented at the American Society for [...]
ASCO GU 2019: Patient perspectives on cytoreductive nephrectomy after CARMENA
The following survey assessed patient views related to cytoreductive nephrectomy [...]
ASCO GU 2019: Questions and lessons moving forward from CARMENA: A surgeon’s perspective
The following paper was presented at the American Society for [...]
